Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-02-14 08:16 am Sale |
2021-12-31 | 13G | International Money Express, Inc. IMXI |
Nantahala Capital Management, LLC | 1,611,488 4.200% |
-522,604![]() (-24.49%) |
Filing History |
2022-02-14 08:16 am Sale |
2021-12-31 | 13G | IMAC Holdings, Inc. BACK |
Nantahala Capital Management, LLC | 79,736 9.100% |
-3,597![]() (-4.32%) |
Filing History |
2022-02-14 08:15 am Sale |
2021-12-31 | 13G | HTG Molecular Diagnostics, Inc. HTGM |
Nantahala Capital Management, LLC | 4,020,180 4.400% |
-343,284![]() (-7.87%) |
Filing History |
2022-02-14 08:14 am Sale |
2021-12-31 | 13G | Golden Entertainment, Inc. GDEN |
Nantahala Capital Management, LLC | 1,071,315 3.700% |
-959,857![]() (-47.26%) |
Filing History |
2022-02-14 08:14 am Sale |
2021-12-31 | 13G | Galmed Pharmaceuticals Ltd. GLMD |
Nantahala Capital Management, LLC | 1,655 1.200% |
-9,050![]() (-84.54%) |
Filing History |
2022-02-14 08:13 am Purchase |
2021-12-31 | 13G | Fortress Biotech, Inc. FBIO |
Nantahala Capital Management, LLC | 605,734 9.600% |
27,006![]() (+4.67%) |
Filing History |
2022-02-14 08:13 am Purchase |
2021-12-31 | 13G | Perella Weinberg Partners PWP |
Nantahala Capital Management, LLC | 1,340,020 3.100% |
1,340,020![]() (New Position) |
Filing History |
2022-02-14 08:12 am Purchase |
2021-12-31 | 13G | FalconStor Software, Inc. FALC |
Nantahala Capital Management, LLC | 651,553 9.200% |
72,507![]() (+12.52%) |
Filing History |
2022-02-14 08:12 am Sale |
2021-12-31 | 13G | Sitio Royalties Corp. STR |
Nantahala Capital Management, LLC | 813,182 6.900% |
-290,750![]() (-26.34%) |
Filing History |
2022-02-14 08:11 am Purchase |
2021-12-31 | 13G | Establishment Labs Holdings Inc. ESTA |
Nantahala Capital Management, LLC | 2,151,454 9.000% |
81,137![]() (+3.92%) |
Filing History |
2022-02-14 08:11 am Sale |
2021-12-31 | 13G | DXP Enterprises, Inc. DXPE |
Nantahala Capital Management, LLC | 1,223,258 6.500% |
-309,912![]() (-20.21%) |
Filing History |
2022-02-14 08:10 am Sale |
2021-12-31 | 13G | DHI Group, Inc. DHX |
Nantahala Capital Management, LLC | 3,726,184 7.500% |
-1,111,529![]() (-22.98%) |
Filing History |
2022-02-14 08:09 am Purchase |
2021-12-31 | 13G | DarioHealth Corp. DRIO |
Nantahala Capital Management, LLC | 1,683,011 9.900% |
848,369![]() (+101.64%) |
Filing History |
2022-02-14 08:09 am Purchase |
2021-12-31 | 13G | Cue Biopharma, Inc. CUE |
Nantahala Capital Management, LLC | 2,539,700 8.000% |
32,928![]() (+1.31%) |
Filing History |
2022-02-14 08:08 am Purchase |
2021-12-31 | 13G | INSU Acquisition Corp. III IIII |
Nantahala Capital Management, LLC | 1,333,332 5.100% |
1,333,332![]() (New Position) |
Filing History |
2022-02-14 08:07 am Purchase |
2021-12-31 | 13G | Avalo Therapeutics, Inc. AVTX |
Nantahala Capital Management, LLC | 2,956 7.500% |
2,956![]() (New Position) |
Filing History |
2022-02-14 08:05 am Purchase |
2021-12-31 | 13G | Catalyst Biosciences, Inc. CBIO |
Nantahala Capital Management, LLC | 700,173 8.800% |
227,249![]() (+48.05%) |
Filing History |
2022-02-14 08:04 am Sale |
2021-12-31 | 13G | BioDelivery Sciences International, Inc. BDSI |
Nantahala Capital Management, LLC | 0 0.000% |
-5,123,671![]() (Position Closed) |
Filing History |
2022-02-14 08:04 am Sale |
2021-12-31 | 13G | Armstrong Flooring, Inc. AFIIQ |
Nantahala Capital Management, LLC | 0 0.000% |
-1,627,441![]() (Position Closed) |
Filing History |
2022-02-14 08:03 am Purchase |
2021-12-31 | 13G | Aptose Biosciences Inc. APTO |
Nantahala Capital Management, LLC | 16,899 8.500% |
738![]() (+4.57%) |
Filing History |